About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Pediatric Epilepsy Database | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT00204360

Pediatric Epilepsy Database

The purpose of this database is to collect information for clinical purposes on all children being treated for seizure disorders.

Lead sponsor: University of Alabama at Birmingham•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Alabama at Birmingham

At some point this information may be used to retrospectively review trends in seizure types, diagnostic evaluation and treatment (medical or surgical). The potential data recorded will be that of standard of care provided to these patients, including age, gender, seizure type/classification, diagnostic procedures (eg. EEG, MRI Magnetoencephalography {MEG}, Single Photon Emission Computed Tomography {SPECT}, Positron Emission Tomography {PET}, invasive electrocorticography) and various treatments (medications, diet, or neurosurgical interventions for the treatment of epilepsy). Records in the database will have identifiable information (name, date of birth, date of procedure, medical record number), but these identifying data will be removed, and only nonidentifying data will be used in the event of research completed using information from this clinical database.

Age

0 - 17 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•NONE

Exclusion Criteria

•NONE

Related studies

RECRUITINGPhase 1

Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy

NCT02531880 · Epilepsy

The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy

NCT06097195 · Epilepsy

RECRUITINGPhase 3

A Study to Test the Long-term Safety and Tolerability of Brivaracetam in Study Participants With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

NCT06315322 · Childhood Absence Epilepsy, Juvenile Absence Epilepsy

RECRUITINGPhase 1/2

A Safety, Tolerability, and Preliminary Efficacy of Low-intensity Focused Ultrasound Neuromodulation in Patients With Drug-resistant Epilepsy

NCT06388707 · Drug Resistant Epilepsy, Epilepsy, and more

RECRUITINGPhase 3

Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures

NCT07505004 · Focal Epilepsy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 19, 2007Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment—

Start date—

Last updatedApr 19, 2007

Condition

Locations shown

Children's Hospital of Alabama

Birmingham, Alabama

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 19, 2007Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions